Zotarolimus 5mg 5mg | Purity Not Available
Adooq Bioscience
Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.
More Information Supplier PageSearch Results
Zotarolimus 25mg 25mg | Purity Not Available
Adooq Bioscience
Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.
More Information Supplier PageZotarolimus 2mg 2mg | Purity Not Available
Adooq Bioscience
Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.
More Information Supplier PageP505-15 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 25mg 25mg | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageZM 323881 hydrochloride 25mg 25mg | Purity Not Available
Adooq Bioscience
ZM 323881 is a potent and selective inhibitor of the kinase activity of the human vascular endothelial growth factor receptor 2 (VEGFR2/KDR).
More Information Supplier PageZM 323881 hydrochloride 100mg 100mg | Purity Not Available
Adooq Bioscience
ZM 323881 is a potent and selective inhibitor of the kinase activity of the human vascular endothelial growth factor receptor 2 (VEGFR2/KDR).
More Information Supplier PageZM 323881 hydrochloride 10mg 10mg | Purity Not Available
Adooq Bioscience
ZM 323881 is a potent and selective inhibitor of the kinase activity of the human vascular endothelial growth factor receptor 2 (VEGFR2/KDR).
More Information Supplier Page